Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT01504048
Other study ID # PTS-02
Secondary ID
Status Recruiting
Phase N/A
First received December 29, 2011
Last updated August 5, 2015
Start date June 2009
Est. completion date December 2016

Study information

Verified date August 2015
Source Karolinska University Hospital
Contact Peter T Schmidt, MD, PhD
Phone +46 8 51770000
Email peter.thelin.schmidt@ki.se
Is FDA regulated No
Health authority Sweden: Regional Ethical Review Board
Study type Interventional

Clinical Trial Summary

The purpose of this study is to determine whether chromoendoscopy using Indigo-Carmine dye spray is useful in diagnosing microscopic colitis among patients undergoing colonoscopy due to chronic watery diarrhea.


Description:

Microscopic colitis is a common disease found in 10% to 20% of cases having chronic watery diarrhea. Obvious endoscopically identifiable changes of the mucosal surface are usually absent, thus diagnosing microscopic colitis relies on multiple biopsy sampling from all segments of the colon. Chromoendoscopy using indigo-carmine dye spray might, however, unravel mucosal changes in microscopic colitis (Suzuki 2011).

The aim of this study is to investigate if chromoendoscopy using Indigo-Carmine 0.2-0.5% in patients with chronic watery diarrhea is useful in diagnosing microscopic colitis.


Recruitment information / eligibility

Status Recruiting
Enrollment 150
Est. completion date December 2016
Est. primary completion date June 2016
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Patients with chronic non-bloody diarrhea for at least one month

Exclusion Criteria:

- Patients who decline to participate

- Unable to give informed consent

Study Design

Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic


Intervention

Procedure:
Colonoscopy with Indigo-Carmine Chromoendoscopy
Colonoscopy with chromoendoscopy using 0.2-0.5% Indigo-Carmine solution sprayed in five areas of the large intestine: Cecum, ascending colon, transverse colon, descending colon and rectum. Pictures are taken before and after dye-spraying and biopsies are collected from all segments of the large intestine and rectum.

Locations

Country Name City State
Sweden Karoliniska University Hospital, Dept. of Gastroenterology Stockholm

Sponsors (1)

Lead Sponsor Collaborator
Karolinska University Hospital

Country where clinical trial is conducted

Sweden, 

References & Publications (1)

Suzuki G, Mellander MR, Suzuki A, Rubio CA, Lambert R, Björk J, Schmidt PT. Usefulness of colonoscopic examination with indigo carmine in diagnosing microscopic colitis. Endoscopy. 2011 Dec;43(12):1100-4. doi: 10.1055/s-0031-1291423. Epub 2011 Nov 4. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Detection of microscopic colitis using chromoendoscopy To investigate the usefullness of chromoendoscopy in diagnosing microscopic colitis using 0.2-0.5% Indigo-Carmine dye spray. The golden standard is the results of histological examination of biopsies from the colo-rectal mucosa. 12 month No
See also
  Status Clinical Trial Phase
Active, not recruiting NCT00139165 - Long-Term Treatment of Collagenous Colitis With Budesonide Phase 3
Not yet recruiting NCT03658993 - Rifaximin-treatment of Collagenous Colitis Phase 3
Completed NCT00450086 - Budesonide Capsules vs. Mesalazine Granules vs. Placebo in Collagenous Colitis Phase 3
Completed NCT01928667 - Case-Control Study to Identify Risk Factors for Microscopic Colitis N/A
Completed NCT00180076 - Budesonide for Maintenance Treatment of Collagenous Colitis Phase 3